Healthcare provider profile · identity verified

Jonathan Daniel Colino, NP

Nurse Practitioner · UTICA, NY · NPI 1962736074

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	410	87
Sertraline Hcl	Sertraline Hcl	366	72
Amlodipine Besylate	Amlodipine Besylate	299	78
Atorvastatin Calcium	Atorvastatin Calcium	237	88
Eliquis	Apixaban	205	47
Furosemide	Furosemide	202	50
Lisinopril	Lisinopril	199	39
Losartan Potassium	Losartan Potassium	174	37
Famotidine	Famotidine	173	42
Metoprolol Succinate	Metoprolol Succinate	152	47
Pantoprazole Sodium	Pantoprazole Sodium	148	39
Potassium Chloride	Potassium Chloride	147	52
Torsemide	Torsemide	145	46
Gabapentin	Gabapentin	138	54
Divalproex Sodium	Divalproex Sodium	119	24
Tamsulosin Hcl	Tamsulosin Hcl	118	32
Mirtazapine	Mirtazapine	117	33
Metoprolol Tartrate	Metoprolol Tartrate	104	28
Omeprazole	Omeprazole	102	34
Metformin Hcl	Metformin Hcl	98	30
Allopurinol	Allopurinol	94	27
Buspirone Hcl	Buspirone Hcl	86	15
Cephalexin	Cephalexin	77	35
Donepezil Hcl	Donepezil Hcl	76	20
Trazodone Hcl	Trazodone Hcl	75	14
Prednisone	Prednisone	67	35
Tramadol Hcl	Tramadol Hcl	67	17
Xarelto	Rivaroxaban	66	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	64	36
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	62	suppressed
Duloxetine Hcl	Duloxetine Hcl	61	12
Doxycycline Hyclate	Doxycycline Hyclate	57	43
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	13
Risperidone	Risperidone	56	suppressed
Tradjenta	Linagliptin	55	14
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	54	16
Entresto	Sacubitril/Valsartan	53	suppressed
Finasteride	Finasteride	51	15
Rosuvastatin Calcium	Rosuvastatin Calcium	50	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	12
Carvedilol	Carvedilol	47	14
Spironolactone	Spironolactone	44	14
Clopidogrel	Clopidogrel Bisulfate	43	14
Oxycodone Hcl	Oxycodone Hcl	43	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	16
Lactulose	Lactulose	41	suppressed
Lorazepam	Lorazepam	40	13
Levetiracetam	Levetiracetam	38	suppressed
Memantine Hcl	Memantine Hcl	38	11
Pravastatin Sodium	Pravastatin Sodium	38	14
Simvastatin	Simvastatin	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	12
Lantus	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Mupirocin	Mupirocin	33	19
Glipizide Er	Glipizide	32	suppressed
Insulin Lispro	Insulin Lispro	32	suppressed
Linzess	Linaclotide	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	20
Clonazepam	Clonazepam	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	11
Alendronate Sodium	Alendronate Sodium	29	suppressed
Ozempic	Semaglutide	29	suppressed
Glipizide	Glipizide	28	suppressed
Nystatin	Nystatin	28	25
Baclofen	Baclofen	27	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	27	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Ceftriaxone	Ceftriaxone Sodium	26	20
Clonidine Hcl	Clonidine Hcl	26	suppressed
Alprazolam	Alprazolam	25	11
Diltiazem 24hr Er (La)	Diltiazem Hcl	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	25	suppressed
Methimazole	Methimazole	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	16
Telmisartan	Telmisartan	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	24	16
Bupropion Xl	Bupropion Hcl	23	suppressed
Irbesartan	Irbesartan	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	16
Metformin Hcl Er	Metformin Hcl	20	suppressed
Nyamyc	Nystatin	20	15
Rexulti	Brexpiprazole	20	suppressed
Budesonide	Budesonide	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	12
Calcitriol	Calcitriol	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Brilinta	Ticagrelor	16	suppressed
Digoxin	Digoxin	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Insulin Aspart Flexpen	Insulin Aspart	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	16	11
Tobramycin	Tobramycin	16	12
Valacyclovir	Valacyclovir Hcl	16	suppressed
Insulin Aspart	Insulin Aspart	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Fluconazole	Fluconazole	14	11
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Ondansetron Odt	Ondansetron	14	13
Paliperidone Er	Paliperidone	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Primidone	Primidone	14	suppressed
Azithromycin	Azithromycin	13	13
Lidocaine Hcl	Lidocaine Hcl	13	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Perphenazine	Perphenazine	12	suppressed
Sodium Chloride	0.9 % Sodium Chloride	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error